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 Background: Aspirin is an antiplatelet agent widely used for the preven-
tion of atherothrombosis. The importance of evaluating different methods to
measure platelet function derives from the growing evidence that aspirine
resistance may indicate an increased risk of future cardiovascular events. In
particular, because subacute thrombosis in patients at high risk may be critical
or lethal, platelet function studies may be considered in the patient’s manage-
ment.
Objectives: This study was designed to compare the detection of aspirin
resistance with blinding tests, the platelet function analyzer (PFA)-100 and
optical platelet aggregation.
Methods: We prospectively enrolled 79 with coronary artery disease who
were taking aspirin 100 mg or 250 mg daily for more than 2 months from june
2008 to decembre 2009. Blood samples were obtained from these patients to
analyze platelet aggregation.   We tested for aspirin sensitivity by 3 laboratory
methods: blinding test (BT), optical platelet aggregation (OPA) using adeno-
sine diphosphate (ADP) and arachidonic acid (AA)   and by PFA-100 using
collagen and/or epinephrine and collagen and/or ADP cartridges to measure
aperture closure time.
Results: Aspirin resistance was noted in 54.4%, 48.1% and 59.4% patients
using respectively: blinding test, PFA-100 and optical aggregation .By 3 tests
19 (24 %) of patients were aspirin resistant. Direct comparison of different
laboratory methods to detect aspirin resistance showed very weak or moderate
correlation.
Table : Correlation of different laboratory methods to detect aspirin resistance
Conclusions: This study demonstrates the   very weak correlation between
different laboratory methods. It is clear that this wide variability cannot be
simply explained based on differences in the patient populations studied, but
is likely due to different accuracy of the different assays to detect the pharma-
cological effect of aspirin. 
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Predictive factors of hemorrhage related to anti vitamin K: 50 cases
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Introduction: Hemorrhagic accidents occurring to anti-vitamin K (AVK)
retain a significant impact despite the codification guidance and supervision
by the PT-INR. The search for risk factors (RF) of hemorrhagic stroke is
therefore interesting. Thus, the main objective of our work is to identify  pre-
dictors factors of hemorrhage related to AVK in our patient.
Patients and methods: This is a prospective case-control, spread over 06
months (May-October 2010). We compared the clinical characteristics of 100
patients with an INR < 4 versus 50 patients with an INR > 4 with hemorrhagic
manifestations : demographics, type of AVK, date of administration, indica-
tion, monitoring: terms and rate, adherence, comorbidities stable or thrust, RF
bleeding and associated drugs.The data were analyzed using Epi Info TM6,
the difference between the 02 groups is significant if p < 0.05.
Results: Our study did not confirm some RF as age> 75 years and female
gender (p = 0.98 and p = 0.57 not significant (NS)). However, the introduction
of AVK <3 months is significant between cases and controls (p < 0.01). Acen-
ocoumarol AVK is the choice in the 02 groups. The presence of a backlog
monitoring and compliance are better in the control group (p = 0.58 and p =
0.1NS). Indication seems to have no impact on overdose, the period of moni-
toring well (p = 0.31 NS). Among comorbidities, a history of gastrointestinal
bleeding <18 months was confirmed as RF (p<0.01), heart failure as well
(p < 0.05), while diabetes, chronic renal failure, myocardial of infarction, neo-
plasia, the antecedent of stroke and overdose do not appear to be significant.
regard to intercurrent episodes, only a recent infection was found as
RF(p < 0.02). As for drugs, the bleeding is inherent in our study antibiotic
(p < 0.05), PPI (p <0.02) and lactulose (p < 0.05).
Conclusion: Our study confirms the existence of some known predictors
of overdose, and seems to highlight the risk, few described to date, the asso-
ciation of PPIs with AVK. The distribution of this work within the facility will
help to strengthen the education of patients and practitioners.
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Background: Even with aspirin taken daily, some patients still suffer from
atherothrombotic events. This shows that aspirin may not work for all patients
in this particular group because these patients may have aspirin resistance.
Objectives: This study was designed to determine the prevalence and risk
factors for aspirin resistance in patients with coronary artery disease and if
aspirin resistance is associated with clinical events.
Methods: We prospectively enrolled 79 with coronary artery disease who
were taking aspirin 100 mg or 250 mg daily for more than 2 months from june
2008 to decembre 2009. Blood samples were obtained from these patients to
analyze platelet aggregation. 
 We tested for aspirin sensitivity by 3 laboratory methods: bliding test,
optical platelet aggregation using adenosine diphosphate (ADP) and arachi-
donic acid (AA)   and by PFA-100 using collagen and/or epinephrine and col-
lagen and/or ADP cartridges to measure aperture closure time
Results: Aspirin resistance was noted in 54.4%,48.1% and 59.4%  patients
using  respectively blinding test , PFA-100 and optical aggregation .By 3 tests
19 ( 24 %) of patients were aspirin resistant. By PFA-100 hypertension was
significantly associated with Aspirin resistance .By optical aggregation, the
comparison of baseline characteristics between aspirin resistant and aspirin
responsive patients did not show any significant difference. By blinding test
smoking, platelet count and double angiographic vessel lesions were indepen-
dently associated with Aspirin resistance.
During follow-up, aspirin resistance was not associated with an increased
risk of major adverse events. Stratified multivariate analyses identified obesity
to be independently associated with major adverse long-term outcomes
Conclusions: This study demonstrates the natural history of aspirin resis-
tance in a stable population showing a wide variability between results of dif-
ferent laboratory methods and documenting risk factors for aspirin resistance.
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laboratory methods Coefficient of correlation :r p
BT/ PFA-100 0.26 <0.001
BT/ OPA-ADP -0.24 0.002
BT/ OPA-AA -0.19 0.012
PFA-100/ OPA-AA -0.24 0.002
PFA-100/ OPA-ADP -0.15 0.06
